| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
3 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-01-11 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Entering into Agreement with Bitmedical AG to Distribute the CompuFlo® Epidural Instrument
Across Austria and Switzerland
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 86 ust. 2 Ustawy o ofercie - sprawozdanie rewidenta do spraw szczególnych
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today announced that it has entered into an agreement with Bitmedical AG _“Bitmedical"_
to distribute the CompuFlo® Epidural Instrument and CathCheck™ System, as well as
related disposables in Switzerland and Austria. Bitmedical is a premier distributor
of medical devices and equipment within Switzerland and Austria, supporting many of
the leading global manufacturers in these markets.
The Board of Directors of the Issuer announces that Bitmedical was impressed with
Milestone’s CompuFlo® Epidural System following extensive due diligence and positive
feedback from end users prior to entering this agreement. Bitmedical’s analysis found
CompuFlo’s objective, quantifiable and real-time pressure detection provides a measure
of safety not currently available in epidural anesthesia. In addition to the inclusion
of this extraordinary precision instrument to its product portfolio, Bitmedical looks
forward to working closely with the Issuer to introduce the CompuFlo and CathCheck
System across Austria and Switzerland.
The Board of Directors of the Issuer is pleased to enter into this distribution agreement
with Bitmedical in such a short period of time since its first contact in November
of 2020, which illustrates their confidence in the market potential for its instruments.
The Board of Directors of the Issuer believes that Bitmedical is an ideal distribution
partner as its principals have extensive expertise and proven track records launching
new medical devices in Austria and Switzerland. The Board of Directors of the Company
believes that he deep reach of Bitmedical into Austrian and Swiss hospitals, as well
as their specific expertise in Intensive Care, Cardiac Surgery and Anesthesiology
will further expand the Issuer’s European and international market presence. Besides
his current role as CEO of Bitmedical, Hansruedi Muehlegg has a direct anesthesia
background as a Clinical Registered Nurse Anesthetist, and thus is very familiar with
the challenges associated with epidural procedures. The Board of Directors of the
Issuer believes that Switzerland and Austria are important markets based on the growing
number of epidural procedures in both childbirth and pain management.
The Board of Directors of the Issuer is pleased to welcome Bitmedical as its exclusive
distribution partner in the region. The Issuer and Bitmedical have a shared vision
of applying advanced technological solutions to enhance the patient experience. The
Board of Directors of the Company looks forward to working closely with Bitmedical
in order to educate medical professionals in the region on the benefits of its system,
which provides objective, quantifiable and real-time confirmation when accessing the
epidural space. Penetrating the sizeable Austrian and Swiss markets is an important
step forward in the commercial launch of the CompuFlo Epidural System in Europe. The
Board of Directors of the Issuer looks forward to adding new distributors, hospitals
and key opinion leaders across Europe and worldwide.
The clinical and safety benefits of the CompuFlo Epidural and CathCheck Systems are
backed by extensive published clinical data demonstrating significant reductions in
epidural punctures, as well as complication rates, and contribute to a significant
savings of time on the part of anesthesiologists. Moreover, the CompuFlo Epidural
Instrument has the potential to significantly reduce costs associated with morbidity,
providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck
technology has the potential to transform the monitoring of catheter placement following
an epidural procedure by confirming the placement of a catheter within 2 minutes,
versus 20-40 minutes using conventional methods.
Bitmedical AG is a distribution company for leading international manufacturers in
Switzerland and Austria for over ten years. They represent a number of companies in
the field of ICU, Anesthesiology, Cardiac Surgery, Orthopedics, and Laboratories.
The companies represented include Medtronic, Rivanna and Thermacor and Tahat. The
company is active in Switzerland and Austria with own direct sales organization, technical
support, warehousing, logistics and administration. The company works together with
all University Hospitals in Austria and Swizerland and has offices in Kaiseraugst
Switzerland and Vienna, Austria.
|
|
|
RB_ASO: Entering into Agreement with Bitmedical AG to Distribute the CompuFlo® Epidural Instrument
Across Austria and Switzerland 
